Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Susan Tam
Tavotek Biotherapeutics
Poster(s):
(M1430-02-06) Clinical Evidence of Safety, Prolonged Half-Life, and Low Immunogenicity of Monoclonal Antibodies TAVO101 and TAVO103 Engineered with Multiple Fc Mutations
Monday, May 5, 2025
2:30 PM – 3:30 PM
ET
